The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a ...

The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...

FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...

Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for ...

AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...

The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The threshold between one season and another, between one moment and the next, between one way of being and the next one: ...

In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.

The most recent trading session ended with Astrazeneca (AZN) standing at $78.38, reflecting a -0.66% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's ...

Breast cancer is one of the most-researched illnesses in the world. But some men suffering from the disease say they’re not able to benefit from new research and treatments.

The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.